New treatment for carpal tunnel syndrome in Hispanic women
Official title: Biomechanical treatment of carpal tunnel syndrome for Hispanic women
Funded at University of Arizona · NIH-11014617 · Data updated 2026-11-12
This study is looking at a new non-surgical treatment called carpal arch space augmentation (CASA) to see if it can help Hispanic women with carpal tunnel syndrome feel better and use their hands more easily, comparing it to the usual brace treatment over eight weeks.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $214,900 |
| NIH project number | 3R21AR082111-01A1S1 |
| Project ID | NIH-11014617 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Hispanic women diagnosed with carpal tunnel syndrome.
✕Less likely to help
Patients who do not identify as Hispanic or those who do not have carpal tunnel syndrome may not benefit from this research.
What this research studies
This research investigates a novel non-surgical treatment called carpal arch space augmentation (CASA) for Hispanic women suffering from carpal tunnel syndrome. The study aims to evaluate the effectiveness of CASA in relieving symptoms and improving hand function compared to standard brace treatment. Participants will be randomly assigned to receive either the CASA intervention or the standard-of-care treatment over an 8-week period, with outcomes measured through patient-reported symptoms and functional assessments. The focus on Hispanic women addresses a significant health disparity in this population.
Why it matters
Potential benefit: If successful, this research could provide a more effective non-surgical treatment option for carpal tunnel syndrome, potentially reducing the need for surgery.
How similar studies have gone: While there is ongoing research in carpal tunnel syndrome treatments, the CASA approach is relatively novel and specifically targets the needs of Hispanic women.
Where this research is happening
-
University of Arizona
Tucson, United States Active
Researchers
- Principal investigator: Li, Zong-Ming — University of Arizona
- Study coordinator: Li, Zong-Ming
Related research
Other NIH-funded projects on the same topics.
-
How aged cells contribute to carpal tunnel syndrome
This project tests whether clearing out aged 'senescent' cells in the wrist's connective tissue can reduce scarring and nerve pressure for people with carpal tunnel syndrome.
-
Understanding how aging cells contribute to Carpal Tunnel Syndrome
This study is looking at how aging cells might play a part in causing Carpal Tunnel Syndrome, which affects many people, and it aims to find ways to treat this condition by focusing on those aging cells to help improve symptoms for patients.
-
Using brain stimulation to improve physical therapy for carpal tunnel syndrome
This study is exploring a new way to help people with carpal tunnel syndrome by using a special non-invasive treatment that targets how the brain processes pain, aiming to make physical therapy more effective and reduce chronic pain.
-
Matrix Rhythm Therapy for Carpal Tunnel Syndrome
This study tests whether adding Matrix Rhythm Therapy to standard care helps people with mild-to-moderate carpal tunnel syndrome improve symptoms, hand function, grip and pinch strength, and quality of life.
-
Carpal tunnel release vs placebo surgery in Finland
In this trial, people with carpal tunnel syndrome are randomly assigned to either standard carpal tunnel surgery or a pretend surgery to see if relief comes from the operation itself or from placebo effects.
-
High-intensity laser therapy for carpal tunnel syndrome
This trial will test whether high-intensity laser therapy helps adults 18–65 with mild-to-moderate carpal tunnel syndrome reduce pain and improve nerve function and hand strength compared with a sham procedure.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.